Race against time: new hope for stroke patients missed by current treatment window
NCT ID NCT06954155
Summary
This study is testing whether a clot-busting drug called tenecteplase can help people recover from a stroke even if given 1 to 3 days after symptoms start. It will compare the drug against standard medical care in 330 adults who had a stroke caused by a blocked brain artery. The main goal is to see if more people can return to near-normal function 90 days after treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing tiantan hospital
RECRUITINGBeijing, 100070, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.